Miltenyi Biotec
Miltenyi Biotec home - back to start page
Miltenyi Biotec
  • MACS® Cell Analysis
Miltenyi Biotec
Miltenyi Biotec
Miltenyi Biotec
Miltenyi Biotec
Clinical
MiltenyiBiotec
for human cells for human cells General topics
for human cells for human cells Crohn’s disease
for human cells for human cells Systemic lupus erythematosus
for human cells for human cells Systemic sclerosis
Research
MiltenyiBiotec
for human cells for human cells Overview
Miltenyi Biotec
Systemic sclerosis
Systemic sclerosis has been treated in clinical trials by autologous stem cell transplantation. The transplanted cells were additionally purified by using the CliniMACS® CD34 Separation System prior to re-infusion.
(Vonk et al. (2008) Ann. Rheum. Dis. 67:98–104, Van Laar et.al (2008) Ann Rheum Dis. 67:35-38).

 
Scientific information 
Publications on stem cell transplantation including CD34+ selection:
 
Contact 
 
  Technical information
Miltenyi Biotec
• Contact for info
• Regulatory note

Search this website
Advanced search
Toolbox
Customer login
Contact
Newsletter
Help
Favorites / Prices
Request prices or add products to your favorite list.
Details
Miltenyi Biotec website